Patent intelligence · US
US 8101186
Peptides that block the binding of IgG to FcRn
Peptides that block the binding of IgG to FcRn
Patent details — US 8101186
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 24, 2012
- Expiration
- Jan 19, 2032
- Applicant
- Syntonix Pharmaceuticals, Inc.
- Claims
- 33
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00
Quick answer
US 8101186 (Peptides that block the binding of IgG to FcRn) is held by Syntonix Pharmaceuticals, Inc.. Status: granted. Granted Jan 24, 2012. Expires Jan 19, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Syntonix Pharmaceuticals, Inc.
- Grant date
- Expiration
- Claims
- 33
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P1/04, A61P1/16
More from Syntonix Pharmaceuticals, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12383733
Iontophoresis-based patch type medicine absorption device
granted -
US 12365879
Synthetic chimeric poxviruses
granted -
US 12304901
Selective ligands for tau aggregates
granted -
US 12156897
Magnesium-containing oxytocin formulations and methods of use
granted -
US 12156864
Analogs of cyclobenzaprine and amitryptilene
granted -
US 12097183
Pharmaceutical composition for treating migraine
granted -
US 12090139
Formulations comprising triptan compounds
granted -
US 11998516
Methods and compositions for treating depression using cyclobenzaprine
granted
Frequently asked questions
What is US patent 8101186?
US 8101186 (Peptides that block the binding of IgG to FcRn) is held by Syntonix Pharmaceuticals, Inc.. Status: granted. Granted Jan 24, 2012. Expires Jan 19, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8101186?
Syntonix Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 86 pharmaceutical patents for this assignee.
When does US 8101186 expire?
Our index shows an expiration date of Jan 19, 2032 (6 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.